secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncology Institute, Inc. (TOI)
CIK:        0001799191
Form:       8-K
Filed at:   2023-06-15T23:59:59+00:00
Accession:  0001104659-23-071385
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncology Institute authorizes up to 5M share buyback at ≤$0.75; obtains lender consent
--------------------------------------------------------------------------------

- Board approved repurchase of up to 5M shares of common stock at price not exceeding $0.75 per share.
- Company entered Limited Consent with Deerfield to permit repurchases on or before June 16, 2023, at same price cap.
- Repurchases may be made in open market or negotiated purchases; no obligation to repurchase any shares.
- Limited Consent also waives certain notice requirements under the Facility Agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799191/000110465923071385/0001104659-23-071385-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799191/000110465923071385/tm2318791d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-071385

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer